The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of function-enhanced, re-activatable, dual-specific CAR T cells pre-loaded with oncolytic virus for immunotherapy of high-grade glioma.
 
Mason Webb
No Relationships to Disclose
 
Jason Tonne
No Relationships to Disclose
 
Jill Thompson
No Relationships to Disclose
 
Jose Pulido
No Relationships to Disclose
 
Matthew C. Coffey
Employment - Oncolytics
Leadership - Oncolytics
Stock and Other Ownership Interests - Oncolytics
Patents, Royalties, Other Intellectual Property - Oncolytics
 
Houra Loghmani
Employment - Oncolytics; Oncolytics
Stock and Other Ownership Interests - Oncolytics
 
Kevin Joseph Harrington
Honoraria - Arch Oncology (Inst); AstraZeneca (Inst); BMS (Inst); Boehringer Ingelheim (Inst); Codiak Biosciences (Inst); Inzen Therapeutics (Inst); Merck Serono (Inst); MSD (Inst); Oncolys BioPharma (Inst); Pfizer (Inst); Replimune (Inst); Scenic Biotech
Consulting or Advisory Role - Arch Oncology (Inst); AstraZeneca (Inst); BMS (Inst); Boehringer Ingelheim (Inst); Inzen Therapeutics (Inst); Merck Serono (Inst); MSD (Inst); Oncolys BioPharma (Inst); Replimune (Inst)
Speakers' Bureau - BMS (Inst); Merck Serono (Inst); MSD (Inst)
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Replimune (Inst)
 
Hardev S. Pandha
Honoraria - Eisai
Travel, Accommodations, Expenses - Merck
 
Alan Melcher
No Relationships to Disclose
 
Rosa Maria Diaz
No Relationships to Disclose
 
Ian F. Parney
Consulting or Advisory Role - Abbvie (Inst)
Research Funding - Merck Serono
(OPTIONAL) Uncompensated Relationships - Boston Scientific (Inst)
 
Richard Vile
Research Funding - Oncolytics